comparemela.com
8
9
10
11
12
13
14
Latest Breaking News On - Conditional marketing authorisation - Page 7 : comparemela.com
Regulatory approval of COVID-19 vaccine Nuvaxovid
Information for healthcare professionals and the public about the COVID-19 vaccine Nuvaxovid.
United-kingdom
Northern-ireland
Craigavon
Great-britain
European-medicines-agency
Product-characteristics
Patient-information-leaflet
Conditional-marketing-authorisation
Novavax Covid vaccine Nuvaxovid approved by MHRA
Nuvaxovid, the COVID-19 vaccine developed by Novavax, has today been given regulatory approval by the Medicines and Healthcare products Regulatory
United-kingdom
Northern-ireland
Craigavon
Great-britain
Sajid-javid
June-raine
Munir-pirmohamed
Expert-working-group
Department-of-health
Commission-on-human-medicines
European-medicines-agency
Committee-on-immunisation
Novavax COVID-19 vaccine Nuvaxovid approved by MHRA
The vaccine has been approved after meeting the required safety, quality and effectiveness standards.
United-kingdom
Northern-ireland
Craigavon
Great-britain
Sajid-javid
June-raine
Munir-pirmohamed
Expert-working-group
Department-of-health
Commission-on-human-medicines
European-medicines-agency
Committee-on-immunisation
Regulatory approval of COVID-19 Vaccine AstraZeneca
Information for healthcare professionals and the public about COVID-19 Vaccine AstraZeneca.
United-kingdom
Northern-ireland
Craigavon
Great-britain
Astrazeneca
Committee-on-vaccination
European-medicines-agency
Conditional-marketing-authorisation
Human-medicine-regulations
Joint-committee
Product-characteristics
Johnson & Johnson Reports Q4 and Full-Year 2021 Results
/PRNewswire/ Johnson & Johnson (NYSE: JNJ) today announced results for fourth-quarter and full year 2021. "Our 2021 performance reflects continued strength.
South-africa
United-states
Canada
Johnson
Consumer-health-business
Digital-surgery-solutions
European-commission-approves
Microsoft
Paliperidone-palmitate
Maintenance-treatment
Multiple-myeloma-after-first
Conditional-marketing-authorisation
vimarsana © 2020. All Rights Reserved.